Latest S-1 registration statements

Biotricity Inc. files S-1, detailing expansion in cardiac monitoring solutions and AI development, alongside significant financial challenges including recurring losses and going concern doubt.

Farlong Holding Corporation filed an S-1/A amendment for its initial public offering, seeking to raise $14.5 million while disclosing recurring losses and substantial doubt about its ability to continue as a going concern.

BitGo Holdings, a leading digital asset infrastructure company, filed its S-1/A for an initial public offering, showcasing significant revenue growth and increased assets on platform, despite past market volatility.

Oncotelic Therapeutics, a clinical-stage biopharmaceutical company, filed an S-1/A registration statement for the resale of 115.6 million common shares by Mast Hill Fund, LP, while continuing to face substantial doubt about its ability to continue as a going concern.

Cycurion, Inc. filed an S-1 registration statement for the resale of nearly 5 million common shares by a selling stockholder and outlined a recent $6 million private placement, while reporting significant Q3 2025 net losses and ongoing going concern doubts.

Jade Biosciences filed a Form S-1 to register 3.21 million shares for resale from its December 2025 $45 million PIPE, with no proceeds to the company.

Splash Beverage Group, Inc. filed an S-1 registration statement for the resale of up to 7.76 million common shares by selling stockholders, highlighting severe liquidity issues, recurring losses, and a critical need for capital to resume operations and pursue new ventures.

Graphjet Technology, a graphene and graphite producer, is appealing a Nasdaq delisting while reporting significant net losses and negative working capital, despite patented biomass conversion technology.

CH4 Natural Solutions Corporation files for a $300M IPO, offering units of Class A shares and warrants, but faces significant dilution and a management team with a mixed SPAC track record including multiple failures and ongoing litigation.

Estrella Immunopharma, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of up to 2,541,206 shares of common stock by selling stockholders, while reporting continued operating losses and a going concern doubt.

cbdMD, Inc. filed an S-1/A to register 1.7 million common shares for resale by Series B Preferred Stock holders, while detailing recent capital raises, reduced operating losses, and significant regulatory challenges.

BNB Plus Corp. files an S-1/A to register 18.7 million shares for resale by selling stockholders, detailing its new BNB-focused digital asset treasury strategy and ongoing LineaRx biopharmaceutical business.

American Battery Materials Inc. filed an S-1/A registration statement for a public offering of 1,550,388 shares to fund its Lisbon Valley lithium and magnesium extraction project in Utah.

Onconetix, Inc. is registering nearly 30 million shares for resale by institutional investors, while simultaneously facing substantial doubt about its ability to continue as a going concern and abandoning its ENTADFI product.

Movano Inc. is undergoing a reverse merger with AI cloud computing company Corvex Inc., simultaneously establishing a $1 billion committed equity facility with Chardan Capital Markets LLC and addressing Nasdaq listing compliance issues.

Fusemachines Inc. has filed an S-1 registration statement for the issuance and resale of common stock and warrants following its business combination, while auditors express substantial doubt about its ability to continue as a going concern.

Momentus Inc. files S-1 to register 1.2 million shares for resale by existing stockholders amidst significant financial challenges and ongoing Nasdaq compliance concerns.

Odyssey Health files S-1 for the resale of 18 million common shares by Mast Hill Fund, L.P., with potential for up to $25 million in future funding.

iSpecimen Inc. filed an S-1/A to register 1,559,828 shares for resale by selling stockholders, while also detailing its new $200 million Solana blockchain-based corporate treasury reserve initiative and ongoing Nasdaq compliance challenges.

Heritage Distilling Holding Company, Inc. reported a significant net income of $185.9 million in Q3 2025, primarily driven by a $245.8 million gain from its new $IP Token cryptocurrency treasury strategy, despite a decline in its traditional craft spirits business.

Celularity Inc. filed an S-1 registration statement for the resale of up to 15.9 million Class A Common Stock shares by existing stockholders, while disclosing substantial doubt about its ability to continue as a going concern.

X3 Acquisition Corp. Ltd., a newly formed SPAC, filed an S-1/A for its initial public offering of 20 million units at $10.00 each, targeting the financial services industry for a business combination.

Semnur Pharmaceuticals files an S-1/A registration statement detailing its recent business combination, ongoing clinical development for its lead non-opioid pain candidate SP-102, and significant financial losses.

Snail, Inc. files an S-1/A to register 5.4 million Class A common stock shares for resale by investors, following significant net losses and a decline in revenue.

Guident Corp. has filed an S-1/A registration statement for its initial public offering, seeking to raise approximately $12.94 million to fund the commercialization of its autonomous vehicle and robot remote monitoring and control platform, despite a history of significant net losses and a 'going concern' warning from its auditors.

Envoy Medical, a hearing health company, is conducting a new offering of common stock and warrants to fund operations, while simultaneously addressing Nasdaq compliance issues and ongoing clinical trials for its Acclaim CI.

DeFi Development Corp. files S-1 for new Variable Rate Series C Perpetual Preferred Stock, aiming to fund its digital asset treasury strategy and real estate platform.

Splash Beverage Group, Inc. (SBEV) has not generated revenue since March 2025, raising substantial doubt about its ability to continue as a going concern, despite securing a $35 million equity line of credit.

K2 Capital Acquisition Corporation files Amendment No. 3 to its S-1 registration statement, outlining its proposed initial public offering, trust account mechanics, and corporate governance.

Onfolio Holdings Inc. filed an S-1 registration statement for the resale of up to 36,201,104 shares of common stock by selling stockholders, primarily from convertible notes and rights.